Related Experiment Video

Updated: Aug 7, 2026

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

[Diagnostic features for the early variant of caseous pneumonia]

B S Kibrik, O G Chelnokova

    Problemy Tuberkuleza I Boleznei Legkikh
    |July 21, 2006
    PubMed

    Insights

    An early variant of caseous pneumonia was identified in 35% of patients. Prompt intensive therapy for this early pneumonia variant led to recovery in 63% and no fatalities.

    Area of Science:

    • Pulmonology
    • Infectious Diseases
    • Critical Care Medicine

    Background:

    • Caseous pneumonia presents diagnostic challenges.
    • Early identification is crucial for effective treatment outcomes.

    Purpose of the Study:

    • To identify and characterize an early variant of caseous pneumonia.
    • To evaluate the efficacy of intensive therapeutic strategies for this early variant.

    Main Methods:

    • Analysis of clinical, X-ray, and laboratory data from 312 patients.
    • Application of intensive etiotropic and pathogenetic therapies, including regional lymphotropic therapy and extracorporeal immune pharmacotherapy.

    Main Results:

    • An early variant of caseous pneumonia was identified in 35% of patients, marked by restricted lesions and absence of severe organ dysfunction.
    • Intensive therapy resulted in cessation of bacterial isolation in 81% of patients.
    • Clinical recovery was achieved in 63% of patients with the early variant, with no fatal cases.

    Conclusions:

    • The early variant of caseous pneumonia is a distinct initial stage.
    • Clinical and X-ray findings are valuable for early diagnosis.
    • Intensive therapeutic interventions improve outcomes for patients with early-stage caseous pneumonia.

    More Related Videos

    Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

    Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

    Published on: March 1, 2024

    Related Concept Videos

    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pulmonary Tuberculosis II01:28

    Pulmonary Tuberculosis II

    Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
    Here is a detailed explanation of its pathophysiology:
    Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...